Somewhat Favorable News Coverage Somewhat Unlikely to Affect AAC (AAC) Stock Price

News articles about AAC (NYSE:AAC) have been trending somewhat positive on Thursday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores nearest to one being the most favorable. AAC earned a news sentiment score of 0.12 on Accern’s scale. Accern also assigned news stories about the company an impact score of 46.6990851323781 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the immediate future.

AAC has been the topic of a number of research reports. Zacks Investment Research downgraded shares of AAC from a “hold” rating to a “sell” rating in a report on Monday, October 9th. Raymond James Financial raised shares of AAC from a “mkt perform” rating to an “outperform” rating in a research note on Friday, November 3rd. Cantor Fitzgerald reissued a “buy” rating and issued a $14.00 price objective on shares of AAC in a research note on Wednesday, September 27th. Finally, UBS raised shares of AAC from a “market perform” rating to an “outperform” rating in a research note on Friday, November 3rd. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and three have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $10.00.

Shares of AAC (AAC) traded down $0.49 during trading hours on Thursday, hitting $8.62. 172,600 shares of the company’s stock were exchanged, compared to its average volume of 133,211. AAC has a 1-year low of $5.99 and a 1-year high of $13.06. The stock has a market cap of $218.63, a PE ratio of 14.02 and a beta of 1.95. The company has a quick ratio of 3.28, a current ratio of 3.28 and a debt-to-equity ratio of 1.42.

AAC (NYSE:AAC) last issued its quarterly earnings data on Wednesday, November 1st. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.05 by $0.07. AAC had a negative net margin of 0.42% and a positive return on equity of 9.64%. The business had revenue of $80.42 million during the quarter, compared to analysts’ expectations of $74.49 million. During the same period last year, the company posted $0.19 EPS. The business’s revenue was up 14.0% on a year-over-year basis. equities research analysts forecast that AAC will post 0.54 earnings per share for the current year.

In related news, Chairman Michael T. Cartwright sold 250,000 shares of AAC stock in a transaction dated Wednesday, November 15th. The shares were sold at an average price of $9.63, for a total transaction of $2,407,500.00. Following the completion of the transaction, the chairman now directly owns 2,880,490 shares of the company’s stock, valued at approximately $27,739,118.70. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director W Larry Cash purchased 10,000 shares of the company’s stock in a transaction that occurred on Thursday, November 30th. The shares were purchased at an average cost of $9.07 per share, with a total value of $90,700.00. Following the completion of the purchase, the director now owns 25,000 shares in the company, valued at approximately $226,750. The disclosure for this purchase can be found here. Company insiders own 37.30% of the company’s stock.

TRADEMARK VIOLATION WARNING: This news story was first posted by Week Herald and is the property of of Week Herald. If you are viewing this news story on another site, it was copied illegally and reposted in violation of international copyright & trademark law. The correct version of this news story can be read at

About AAC

AAC Holdings, Inc is a provider of inpatient and outpatient substance abuse treatment services for individuals with drug and alcohol addiction. The Company performs drug testing and diagnostics laboratory services and provides physician services to its clients. As of June 30, 2016, the Company operated 12 residential substance abuse treatment facilities located throughout the United States, focused on delivering clinical care and treatment solutions across 1,139 beds, which includes 636 licensed detoxification beds, and 18 standalone outpatient centers.

Insider Buying and Selling by Quarter for AAC (NYSE:AAC)

Receive News & Ratings for AAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AAC and related companies with's FREE daily email newsletter.

Leave a Reply